SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Rule 8.1- (Xploite plc) - Replacement

12 Apr 2010 17:06

RNS Number : 0621K
Xploite PLC
12 April 2010
 



RULE 8 AMENDMENT

 

The 'Rule 8.1 - Xploite plc' announcement released on 12/04/2010 at 13.36 under RNS No 0390K has been amended.

 

Amendments are identified with an asterisk (*).

 

The full amended text is shown below.

 

 

FORM 8.1

 

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)

 

 

1...KEY INFORMATION

 

Name of person dealing (Note 1)

Ian Smith (Chief Executive)

Company dealt in

Xploite plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

10p Ordinary

Date of dealing

09/04/10

 

 

2...INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

4,070,575

18.7%

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell*

-

-

-

-

Total

4,070,575

18.7%

-

-

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

-

-

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell

-

-

-

-

Total

-

-

-

-

 

(c)..Rights to subscribe (Note 3)*

 

Class of relevant security:

Details

Ordinary Shares of 10p each

Call Option ('A' Options), which shall expire on 19 March 2017, are held in respect of 344,828 ordinary shares at an exercise price of 29p upon satisfaction of a share price performance condition of 58p.

 

3...DEALINGS (Note 4)

 

(a)..Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

Purchase

220,513

36p

 

 

(b)..Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

n/a

 

 

(c)..Options transactions in respect of existing securities

(i)..Writing, selling, purchasing or varying

 

Product

name,e.g.

call option

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option relates

(Note 7)

Exercise

price

Type, e.g.

American,

European

etc.

Expiry

date

Option money

paid/received

per unit (Note 5)

 

n/a

 

(ii)..Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

n/a

 

(d)..Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

n/a

 

4...OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Further details of the rights to subscribe referred to above are available in the Scheme Document which is available in the investor relations section of the company's website: http://www.xploite.co.uk/investors/recommended-proposal.php

 

Is a Supplemental Form 8 attached? (Note 9)........ NO

 

Date of disclosure

12 April 2010

Contact name

Ian Smith

Telephone number

+44 (0) 870 737 2001

Name of offeree/offeror with which associated

Xploite plc

Specify category and nature of associate status (Note 10)

Director of Xploite plc

 

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCGGUQCCUPUGAP
Date   Source Headline
31st Mar 20235:03 pmRNSSatisfaction of Deferred Consideration & TVR
14th Mar 20234:01 pmRNSTR-1: Notification of Major Holdings
6th Mar 20237:00 amRNSTrading Update and Notice of Results
18th Jan 20233:07 pmRNSExercise of Options and Total Voting Rights
15th Dec 20227:00 amRNSDirectorate Change
2nd Nov 20227:00 amRNSDirector Share Purchase & PDMR Dealing
28th Oct 20221:51 pmRNSExercise of Options
28th Sep 20227:00 amRNSInterim results
5th Sep 20227:00 amRNSTwo significant US contract wins
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
27th Jul 202211:46 amRNSDirector Share Purchases & PDMR Dealings
19th Jul 20227:00 amRNSContract with European aerospace company
11th Jul 20227:00 amRNSContract win
21st Jun 202212:15 pmRNSResult of AGM
21st Jun 20227:00 amRNSAGM Statement and Trading Update
20th Jun 202212:35 pmRNSHolding(s) in Company
8th Jun 20227:00 amRNSFirst significant contract with High Speed Two
23rd May 20227:00 amRNSFirst contract with the State of New York
18th May 20224:47 pmRNSReport and Accounts and Notice of AGM
16th May 20227:00 amRNSAttendance at the Mello Investor Conference
11th May 20227:00 amRNS$1.4m expansion contract with State of California
27th Apr 20227:00 amRNSFinal Results
6th Apr 20229:30 amRNSNotice of Results and Investor Presentation
4th Mar 20223:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTrading update
17th Feb 20227:01 amEQSEdison Investment Research Limited: 1Spatial (SPA) - Validating spatial data across the globe
16th Feb 20227:00 amRNSNG911 contract win with State of Montana
7th Dec 20217:00 amRNSMulti-year contract with Rural Payments Agency
19th Oct 20215:15 pmRNSHolding(s) in Company
19th Oct 20212:18 pmRNSHolding(s) in Company
13th Oct 20217:00 amRNSMulti-year framework agreement
29th Sep 20217:00 amRNSInterim Results
27th Sep 20217:00 amRNSPartnership Contract Win for UK Government project
13th Sep 20217:00 amRNSContract to support UK Geospatial Commission
20th Aug 20217:00 amRNSNotice of Results
13th Jul 20217:00 amRNS1Spatial unveils new 1Integrate 3D rules engine
23rd Jun 202112:11 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
26th May 20211:24 pmRNSReport and Accounts and Notice of AGM
17th May 20217:00 amRNSUK Patent Granted
28th Apr 202112:41 pmRNSDirector Share Purchases
28th Apr 20217:00 amRNSFinal Results
15th Apr 20217:00 amRNSGoogle, Inc extends contract with 1Spatial
1st Apr 20217:00 amRNSMulti Year Contract
24th Mar 202110:26 amRNSHolding(s) in Company
19th Mar 20217:00 amRNSEsri Partner Network Award
18th Mar 20217:00 amRNSIntegration Update
12th Mar 20213:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.